4th Quarter - Report

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Labor-Health and Human Services Appropriations seeking additional Food and Drug Administration (FDA) funding. Communication to FDA on Rescheduling Hydrocodone containing mediations.

LobbyistCovered position, as disclosed
JOSEPH M HILL —
BRIAN M MEYER —
KAREN NOONAN —
CHRISTOPHER J TOPOLESKI —

Contacted: Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); SENATE

Medicare/Medicaid MMM

Communication with Centers for Medicare and Medicaid Services regarding Innovation Center and direct reimbursement under Medicare program.

LobbyistCovered position, as disclosed
JOSEPH M HILL —
BRIAN M MEYER —
KAREN NOONAN —
CHRISTOPHER J TOPOLESKI —

Contacted: SENATE; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA)

Pharmacy PHA

H.R. 6413, support for the "Transitional Care Act of 2012." Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communication to FDA on approval of biosimilars and drug safety. Communications to Health Resources and Services Administration on 340B drug discount program. Communication with FDA and Centers for Disease Control and Prevention on compounding.Provided input on H.R. 6584, "Verifying Authority and Legality In Drug Compounding Act of 2012."

LobbyistCovered position, as disclosed
JOSEPH M HILL —
BRIAN M MEYER —
KAREN NOONAN —
CHRISTOPHER J TOPOLESKI —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 6584 (112th), H.R. 6413 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.